The country’s first intranasal COVID vaccine iNCOVACC by Bharat Biotech has recently received DCGI approval for primary immunization against the infection for people above the age of 18...
Bharat Biotech recently sought approval for its intranasal Covid vaccine candidate, BBV154, as two-dose vaccine as well as booster dose. It submitted data from Phase 3 clinical trials of...
A vaccine manufacturer based in Hyderabad, Biological E has received emergency use authorization (EUA) from the drug regulator of India for its Covid-19 vaccine for children aged 12...
The Drug controller General of India has approved the COVAXIN booster trials. These boosters were produced by Bharat Biotech, the same company that produces COVAXIN. The boosters are...
The Drug regulator in India has granted conditional market approval for the COVISHIELD and COVAXIN vaccines. This means that the private hospitals shall administer the vaccines. However, the...
The Padma Awards 2022 is to be conferred to vaccine makers to semiconductor market rulers. This time, the Padma awards are being presented to a diversified list of...
The World Health Organisation (WHO) has recommended for third dose of immunocompromised, following a four-day meeting of the “Strategic Advisory Group of Experts (SAGE) on Immunization”. The final...
India’s first nasal vaccine against COVID-19 has received the nod to conduct phase 2 and 3 clinical trials by the Department of Biotechnology. Key Points Nasal Covid Vaccine...
The India Ratings and Research (Ind-Ra) recently said the estimated cost to vaccinate all the Indians of age 18 years will be Rs 67,193 crores. This is 0.36%...
The Government of India recently approved the transfer of technology from Bharat Biotech to Hafkine Institute. COVAXIN COVAXIN is one of the two drugs that is currently administered...
